Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Microsoft
MSFT
|
+$981M |
| 2 |
Chevron
CVX
|
+$718M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$469M |
| 4 |
Shopify
SHOP
|
+$439M |
| 5 |
Meta Platforms (Facebook)
META
|
+$401M |
Top Sells
| 1 |
Amazon
AMZN
|
+$675M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$633M |
| 3 |
Tesla
TSLA
|
+$543M |
| 4 |
Verizon
VZ
|
+$535M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$377M |
Sector Composition
| 1 | Healthcare | 19.41% |
| 2 | Technology | 16.81% |
| 3 | Consumer Staples | 11.14% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Financials | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3801
Gain Therapeutics
GANX
$62.2M
| $119K | ﹤0.01% |
+33,100
| New | +$119K |
|
|
BYU
3802
DELISTED
BAIYU Holdings, Inc. Common Stock
BYU
| $119K | ﹤0.01% |
1,891
-1,792
| -49% | -$113K |
|
3803
Knightscope
KSCP
$56.6M
| $118K | ﹤0.01% |
+784
| New | +$118K |
|
3804
Minerva Neurosciences
NERV
$15M
| $118K | ﹤0.01% |
35,611
-13,133
| -27% | -$43.5K |
|
|
VRNA
3805
Verona Pharma
VRNA
$9.2B
| $118K | ﹤0.01% |
+28,200
| New | +$118K |
|
|
NBEV
3806
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
| $118K | ﹤0.01% |
527,320
+350,620
| +198% | +$78.5K |
|
3807
Perspective Therapeutics
CATX
$240M
| $117K | ﹤0.01% |
37,709
-4,023
| -10% | -$12.5K |
|
|
ELYS
3808
DELISTED
Elys Game Technology, Corp. Common Stock
ELYS
| $117K | ﹤0.01% |
+159,029
| New | +$117K |
|
|
DBTX
3809
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
| $116K | ﹤0.01% |
27,600
+6,685
| +32% | +$28.1K |
|
3810
American Coastal Insurance
ACIC
$526M
| $115K | ﹤0.01% |
73,426
-16,800
| -19% | -$26.3K |
|
3811
Aurora
AUR
$10B
| $115K | ﹤0.01% |
+60,400
| New | +$115K |
|
3812
IGC Pharma
IGC
$37.4M
| $115K | ﹤0.01% |
+217,749
| New | +$115K |
|
|
ALLR
3813
Allarity Therapeutics
ALLR
$26.5M
| – | – |
0
| – | -$233K |
|
3814
Castor Maritime
CTRM
$19.2M
| $114K | ﹤0.01% |
8,480
+6,810
| +408% | +$91.6K |
|
3815
NanoViricides
NNVC
$23M
| $113K | ﹤0.01% |
60,000
-16,800
| -22% | -$31.6K |
|
3816
Salarius Pharmaceuticals
SLRX
$2.33M
| $113K | ﹤0.01% |
179
+158
| +752% | +$99.7K |
|
3817
Telesat
TSAT
$312M
| $113K | ﹤0.01% |
10,100
-24,000
| -70% | -$269K |
|
3818
Yunhong Green CTI Ltd
YHGJ
$18M
| $113K | ﹤0.01% |
158,366
-2,400
| -1% | -$1.71K |
|
|
AXLA
3819
DELISTED
Axcella Health Inc. Common Stock
AXLA
| $113K | ﹤0.01% |
2,228
+272
| +14% | +$13.8K |
|
3820
Empire State Realty Trust
ESRT
$1.3B
| $112K | ﹤0.01% |
15,900
-151,400
| -90% | -$1.07M |
|
3821
Intellicheck
IDN
$108M
| $112K | ﹤0.01% |
55,200
+38,303
| +227% | +$77.7K |
|
3822
Roundhill Ball Metaverse ETF
METV
$324M
| $112K | ﹤0.01% |
+13,900
| New | +$112K |
|
|
FNCH
3823
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
| $110K | ﹤0.01% |
1,290
-210
| -14% | -$17.9K |
|
|
BDRX
3824
Biodexa Pharmaceuticals
BDRX
$3.56M
| $109K | ﹤0.01% |
+1
| New | +$109K |
|
3825
Udemy
UDMY
$1B
| $109K | ﹤0.01% |
10,700
-28,900
| -73% | -$294K |
|